This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
MOUSE ANTI MTDH
catalog :
VMA00204
quantity :
100 µl
price :
346 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
OTI1E7
reactivity :
human
application :
western blot, immunoprecipitation
product information
EntityType :
PrecisionAb Monoclonal
EntityCategory :
Antibodies
ProductCode :
VMA00204
Description :
MOUSE ANTI MTDH
Specificity :
MTDH
TargetSpecies :
Human
Host :
Mouse
Format :
Purified
Isotypes :
IgG1
Applications :
WB,IP
ApplicationTypes :
Western Blotting,Immunoprecipitation
CrossReactivities :
Mouse,Rat
Clone :
OTI1E7
Quantity :
100 µl
QuantityValue :
100
QuantityType :
ul
GOAccessions :
GO:0005923,GO:0005789,GO:0005730,GO:0016021,GO:0003713,GO:0001085,GO:0000122,GO:0045766,GO:0043123,GO:0043066,GO:0031965,GO:0031663,GO:0016604,GO:0016324,GO:0010508,GO:0051092,GO:0051059,GO:0048471,GO:0046581,GO:0051897
GOTerms :
down regulation of transcription from RNA polymerase II promoter,downregulation of transcription from RNA polymerase II promoter,down-regulation of transcription from RNA polymerase II promoter,inhibition of transcription from RNA polymerase II promoter,negative regulation of transcription from Pol II promoter,transcription co-activator activity,transmembrane,ER membrane,zonula occludens,lipopolysaccharide-mediated signalling pathway,LPS-mediated signaling pathway,down regulation of apoptosis,downregulation of apoptosis,down-regulation of apoptosis,inhibition of apoptosis,activation of I-kappaB kinase/NF-kappaB cascade,stimulation of I-kappaB kinase/NF-kappaB cascade,up regulation of I-kappaB kinase/NF-kappaB cascade,up-regulation of I-kappaB kinase/NF-kappaB cascade,upregulation of I-kappaB kinase/NF-kappaB cascade,activation of angiogenesis,stimulation of angiogenesis,up regulation of angiogenesis,upregulation of angiogenesis,up-regulation of angiogenesis,activation of NF-kappaB,activation of NF-kappaB transcription factor,NF-kappaB activation,activation of protein kinase B signaling cascade,positive regulation of AKT signaling cascade,positive regulation of AKT signalling cascade,positive regulation of PKB signaling cascade,positive regulation of PKB signalling cascade,positive regulation of protein kinase B signalling cascade,stimulation of protein kinase B signaling cascade,up regulation of protein kinase B signaling cascade,upregulation of protein kinase B signaling cascade,up-regulation of protein kinase B signaling cascade
UniprotAccessions :
Q86UE4
Gene :
MTDH
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=92140
EntityFormats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 0.5 mg/ml.
ProductForm :
Purified IgG - liquid
PriceGBP :
262
PriceEUR :
336
PriceUSD :
346 USD
PriceCHF :
366.24
PriceSEK :
3531
PriceNOK :
3599
PriceDKK :
2507
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.